Longwood Fund has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Engrail Therapeutics's $157M Series B+ round in March 2024, alongside Ysios Capital, RiverVest, Red Tree Venture Capital and 6 others. By category, its portfolio leans toward Health and bio (2).

What Longwood Fund invests in

• Health and bio · 2 · 100%

How Longwood Fund invests

Share is of the 1 round on Recent Funding that name Longwood Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Longwood Fund portfolio companies

• EEngrail Therapeutics$157MSeries B+ · Mar 2024
• KKhartis Therapeuticsbacker

Most frequent co-investors

• FF-Prime Capital1 shared round · last Mar 19, 2024
• NNorwest Venture Partners1 shared round · last Mar 19, 2024
• EEight Roads Ventures1 shared round · last Mar 19, 2024
• FForesite Capital1 shared round · last Mar 19, 2024
• YYsios Capital1 shared round · last Mar 19, 2024
• RRiverVest1 shared round · last Mar 19, 2024
• FForbion Capital Partners1 shared round · last Mar 19, 2024
• RRed Tree Venture Capital1 shared round · last Mar 19, 2024
• PPivotal Life Sciences1 shared round · last Mar 19, 2024

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSeventure Partners2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo
• TTenmile2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Longwood Fund, which is a subset of its real portfolio. API: /api/v1/investors/longwood-fund (get a free API key). More: the most active VC firms and new venture capital funds.